8
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Elevated Expression of Ferritin H-Chain mRNA in Metastatic Ovarian Tumor

&
Pages 518-526 | Published online: 11 Jun 2009

References

  • Fidler I J. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990; 50: 6130–6138
  • Liotta L. Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res Treat 1988; 11: 113–124
  • Hart I R, Goode N T, Wilson R E. Molecular aspects of the metastatic cascade. Biochim Biophys Acla 1989; 989: 65–84
  • Nicolson G L. Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression. Cancer Res 1987; 47: 1473–1487
  • Fidler I J, Radinsky R. Genetic control of cancer metastasis. Editorial. J Natl Cancer Inst 1990; 82: 66–68
  • Crickard K, Niedbala M J, Crickard U, et al. Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix. Gynecol Oncol 1989; 32: 163–173
  • Crickard K, Crickard U, Yoonessi M. Human ovarian carcinoma cells maintained on extracellular matrix versus plastic. Cancer Res 1983; 43: 2762–2767
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
  • Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory ManualEd. 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1989
  • Gubler U, Hoffman B J. A simple and very efficient method for generating cDNA libraries. Gene 1983; 25: 263–269
  • Tripathi P K, Chatterjee S K. Simple method for preparing pure lambda phage DNA. Methods Mol Cell Biol 1992; 3: 232–238
  • Vogelstein B, Gillespie D. Preparation and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 1979; 76: 615–619
  • Feinberg A P, Vogelslein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6–13
  • Altschul S F, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990; 215: 403–410
  • Hagen F S, Gray C L, Kuijper J L. Assaying the quality of cDNA libraries. BioTechniques 1988; 6: 340–345
  • Sarcione E J, Smalley J R, Lema M J, et al. Increased ferritin synthesis and release by Hodgkin's disease pripheral blood lymphocytes. Br J Cancer 1977; 20: 339–346
  • Vezzone P, Levi S, Gabri E, et al. Ferritins in malignant and non-malignant lymphoid cells. Br J Haematol 1986; 62: 105–110
  • Guncr G, Kirkali G, Yenisey C, et al. Cy tosol and serum ferritin in breast carcinoma. Cancer Lett 1992; 67: 103–112
  • Vaughn C B, Weinslein R, Bond B, et al. Ferritin content in human cancerous and noncancerous colonic tissue. Cancer Invest 1987; 5: 7–10
  • Weinstein R E, Bond B H, Silberberg B K. Tissue ferritin concentration in carcinoma of the breast. Cancer 1982; 50: 2406–2409
  • Weinstein R E, Bond B H, Silberberg B K, et al. Tissue ferritin concentration and prognosis in carcinoma of the breast. Breast Cancer Res Treat 1989; 14: 349–353
  • Nidbala M J, Madidyalakan R, Malta K, et al. The role of glycosidases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix. Cancer Res 1987; 47: 4634–4641
  • Niedbala M J, Crickard K, Beniacki R J. In vitro degradation of extracellular matrix by human ovarian carcinoma cells. Clin Exp Metast 1987; 5: 181–197
  • Hastie N D, Bishop J O. The expression of three abundance classes of messenger RNA in mouse tissues. Cell 1976; 9: 761–774
  • Travis G H, Sutcliffe J O. Phenol emulsion-enhanced DNA-driven subtractive cDNA cloning: Isolation of low-abundance monkey cortex-specific mRNAs. Proc Natl Acad Sci USA 1988; 85: 1696–1700
  • Schweinfest C W, Henderson K W, Gu J R, et al. Subtraction hybridization of cDNA libraries from colon carcinoma and hepatic cancer. Genet Anal Techn Appl 1990; 7: 64–70
  • Boyd D, Vecoli C, Belcher D M, et al. Structural and functional relationships of human ferritin H and L chains deduced from cDNA clones. J Biol Chem 1985; 260: 11755–11761
  • Stierer M, Rosen H R, Forster E, et al. Placental isoferritin (PLF) in comparison with MCA and CEA in advanced breast cancer—First data from a pilot study. Breast Cancer Res Treat 1991; 19: 283–288
  • Cox R, Gyde O H, Leyland M J. Serum ferritin levels in small cell lung cancer. Eur J Cancer Clin Oncol 1986; 22: 831–835
  • Cunietti E, Locatelli E, Vaiani G, et al. Carcinoembryonic antigen, ferritin, anionic glycoproteins, and their sialic acid content in advanced colorectal cancer. Cancer Detect Prev 1985; 8: 227–232
  • Lugar T A, Linkesch W, Knobler R, et al. Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology 1983; 40: 263–267
  • Ito H, Takagi Y, Ando Y, et al. Serum ferritin levels in patients with cervical cancer. Obstet Gynecol 1980; 55: 358–362
  • Kikyo N, Suda M, Kikyo N, et al. Purification and characterization of a cell growth factor from a human leukemia cell line: Immunological identity with ferritin. Cancer Res 1994; 54: 268–271
  • Rossi M C, Zetter B R. Selective stimulation of prostatic carcinoma cell proliferation by transferrin. Proc Natl Acad Sci USA 1992; 89: 6197–6201
  • Inoue T, Cavanaugh P G, Steck P A, et al. Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials. J Cell Physiol 1993; 156: 212–217

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.